Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
- PMID: 17607801
- PMCID: PMC2932652
- DOI: 10.1002/gps.1858
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study
Abstract
Background: Neuropsychiatric symptoms are nearly universal in dementia, yet little is known about their longitudinal course in the community.
Objective: To estimate point and 5-year period prevalence of neuropsychiatric symptoms in an incident sample of 408 dementia participants from the Cache County Study.
Methods: The Neuropsychiatric Inventory assessed symptoms at baseline and at 1.5 years, 3.0 years, 4.1 years, and 5.3 years. Point prevalence, period prevalence and mean symptom severity at each time point were estimated.
Results: Point prevalence for delusions was 18% at baseline and 34-38% during the last three visits; hallucinations, 10% at baseline and 19-24% subsequently; agitation/aggression fluctuated between 13% and 24%; depression 29% at baseline and 41-47% subsequently; apathy increased from 20% at baseline to 51% at 5.3 years; elation never rose above 1%; anxiety 14% at baseline and 24-32% subsequently; disinhibition fluctuated between 2% and 15%; irritability between 17% and 27%; aberrant motor behavior gradually increased from 7% at baseline to 29% at 5.3 years. Point prevalence for any symptom was 56% at baseline and 76-87% subsequently. Five-year period prevalence was greatest for depression (77%), apathy (71%), and anxiety (62%); lowest for elation (6%), and disinhibition (31%). Ninety-seven percent experienced at least one symptom. Symptom severity was consistently highest for apathy.
Conclusions: Participants were most likely to develop depression, apathy, or anxiety, and least likely to develop elation or disinhibition. Give converging evidence that syndromal definitions may more accurately capture neuropsychiatric co-morbidity in dementia, future efforts to validate such syndromes are warranted.
Copyright (c) 2007 John Wiley & Sons, Ltd.
Conflict of interest statement
CONFLICT OF INTEREST
The authors have no financial or personal relationships which might bias this work.
Figures
Similar articles
-
The course of neuropsychiatric symptoms in dementia: a 3-year longitudinal study.J Am Med Dir Assoc. 2015 May 1;16(5):380-7. doi: 10.1016/j.jamda.2014.12.018. Epub 2015 Feb 14. J Am Med Dir Assoc. 2015. PMID: 25687925
-
Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study.Int J Geriatr Psychiatry. 2006 Sep;21(9):824-30. doi: 10.1002/gps.1567. Int J Geriatr Psychiatry. 2006. PMID: 16955439
-
Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period.Am J Geriatr Psychiatry. 2010 Dec;18(12):1054-65. doi: 10.1097/jgp.0b013e3181f60fa1. Am J Geriatr Psychiatry. 2010. PMID: 21155143
-
Prevalence of Behavioral and Psychological Symptoms of Dementia in Community-Dwelling Dementia Patients: A Systematic Review.Front Psychiatry. 2021 Oct 21;12:741059. doi: 10.3389/fpsyt.2021.741059. eCollection 2021. Front Psychiatry. 2021. PMID: 34744832 Free PMC article.
-
The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.Neurology. 1997 May;48(5 Suppl 6):S10-6. doi: 10.1212/wnl.48.5_suppl_6.10s. Neurology. 1997. PMID: 9153155 Review.
Cited by
-
Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression.Front Nutr. 2021 May 14;8:669846. doi: 10.3389/fnut.2021.669846. eCollection 2021. Front Nutr. 2021. PMID: 34055858 Free PMC article. Review.
-
Treatment and Management of Dementia Due to Alzheimer's Disease.Curr Treat Options Neurol. 2015 Aug;17(8):363. doi: 10.1007/s11940-015-0363-4. Curr Treat Options Neurol. 2015. PMID: 26135252
-
Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards.Int J Geriatr Psychiatry. 2021 Mar;36(3):443-451. doi: 10.1002/gps.5442. Epub 2020 Oct 16. Int J Geriatr Psychiatry. 2021. PMID: 33022804 Free PMC article.
-
Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults With Dementia and Major Depressive Disorder.Am J Geriatr Psychiatry. 2019 Aug;27(8):794-805. doi: 10.1016/j.jagp.2019.02.002. Epub 2019 Feb 7. Am J Geriatr Psychiatry. 2019. PMID: 30926273 Free PMC article.
-
Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke-Korsakoff Syndrome: A Nationwide Register Study in Finland.J Clin Med. 2023 Jun 25;12(13):4263. doi: 10.3390/jcm12134263. J Clin Med. 2023. PMID: 37445298 Free PMC article.
References
-
- Aalten P, de Vugt ME, Louisberg R, et al. Behavioural problems in dementia: a factor analysis of the Neuropsychiatric Inventory. Dement Geriatr Cogn Disord. 2003;15:99–105. - PubMed
-
- Aalten P, de Vugt ME, Jaspers N, et al. The course of neuropsychiatric symptoms in dementia. Part 1: findings from the two year longitudinal Maasbed study. Int J Geriatr Psychiatry. 2005;15:523–530. - PubMed
-
- Breitner JCS, Wyse BW, Anthony JC, et al. APOE-epsilon 4 count predicts age when prevalence of Alzheimer’s disease increases- then declines: the Cache County Study. Neurology. 1999;53:321–331. - PubMed
-
- Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314. - PubMed
-
- Frisoni GB, Rozzini L, Gozzetti A. Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement Geriatr Cogn Dis. 1999;10:130–138. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical